Verified75% confidenceFactExact time
Under the major global regulatory frameworks, medical AI products are classified as Software as a Medical Device (SaMD); the U.S. FDA requires clearance through the 510(k) or PMA process, China's NMPA requires completion of Class III medical device registration, and the EU regulates them through the MDR.
3
Sources
75%
Confidence
Long-term
Relevance
7/13/2026
First Seen
Sources
疟疾细胞AI识别：医学影像分类实践全解析
Related Claims
UnverifiedThe U.S. FDA has established a dedicated Digital Health Center of Excellence (DHCoE) to conduct pre-market review of AI/ML software as a medical device (SaMD).75% similarUnverifiedFDA approval requirements for medical imaging equipment and diagnostic software, as well as varying telemedicine regulations across US states, constitute compliance barriers for European health companies entering the US market.72% similarUnverifiedAs of 2024, the FDA has approved more than 800 AI/ML medical devices, with nearly all approvals positioning them as assistive diagnostic tools rather than independent decision-making systems.72% similarUnverifiedIn the United States, consumer health apps that claim to diagnose, treat or prevent disease may fall within the FDA's definition of medical devices; in China, services providing psychological assessment and intervention must comply with regulations on mental health and internet-based medical care.70% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/502874API
curl https://kongchang.com/api/v1/knowledge/claims/502874MCP
get_claim(id=502874)